| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other (expense) income, net | -19 | 1,266 | 549 | 567 |
| Net loss | -1,421 | -2,709 | -2,891 | -2,072 |
| Other comprehensive loss | -17 | -1,107 | -533 | -527 |
| Comprehensive loss | -1,438 | -3,816 | -3,424 | -2,599 |
| Diluted average shares | - | - | - | 20,310,000 |
| Net loss per share applicable to common stockholders, basic and diluted (in dollars per share) | -0.54 | -1.24 | -0.12 | -0.1 |
| Us-gaap_earningspersharediluted | -0.54 | -1.24 | -0.12 | -0.1 |
| Weighted average number of common shares outstanding, basic and diluted (in shares) | 2,616,000 | 2,180,000 | 25,393,000 | 20,310,000 |
EKSO BIONICS HOLDINGS, INC. (EKSO)
EKSO BIONICS HOLDINGS, INC. (EKSO)